ClinConnect ClinConnect Logo
Search / Trial NCT06002906

The Use of Indocyanine Green to Visualize Blood Flow to the Gastrojejunostomy During Bariatric Surgery.

Launched by UNIVERSITY HEALTH NETWORK, TORONTO · Aug 9, 2023

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a special imaging technique called NIF imaging to help doctors see blood flow to the stomach and intestines during a specific weight-loss surgery called Roux-en-Y gastric bypass. The main goal is to determine if this method can help reduce problems like ulcers, leaks, and narrowing of the connection between the stomach and intestines after surgery.

If you are over 18, eligible for bariatric surgery in Ontario, and willing to follow up with the program for behavioral and dietary changes, you might qualify to participate. Participants will receive the usual care for their surgery, along with this additional imaging technique to ensure everything is functioning well. It's important to note that those with certain allergies, ongoing substance abuse, or specific medical conditions may not be able to join the study. Overall, this trial aims to improve surgical outcomes and long-term health for those undergoing bariatric surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Capacity to provide informed consent.
  • Over the Age of 18.
  • Eligible for bariatric surgery in Ontario and deemed an appropriate candidate for RYGB surgery by the bariatric program.
  • Commit to follow-up within the bariatric program, including behavioral and dietary modifications designed to aid in sustained weight-loss.
  • Treatment of marginal ulcer with the revisional surgery.
  • Exclusion Criteria:
  • Not willing to participate in study
  • Contraindication to, or not planned to undergo RYGB
  • Known allergy to indocyanine green or Sodium Iodide
  • Is participant pregnant or planning to get pregnant in next two years
  • Ongoing substance abuse or active smoking
  • Bleeding diathesis or Coagulopathy
  • Unwilling to take PPI medication Post operatively

About University Health Network, Toronto

University Health Network (UHN), based in Toronto, is a leading academic health sciences center dedicated to advancing patient care through innovative research and education. As a prominent sponsor of clinical trials, UHN integrates cutting-edge scientific discoveries with clinical practice, facilitating the development of new therapies and treatment modalities. With a commitment to improving health outcomes, UHN collaborates with a diverse network of researchers, healthcare professionals, and industry partners, fostering an environment that prioritizes patient safety and ethical standards in clinical research. Through its extensive resources and expertise, UHN plays a pivotal role in transforming healthcare and enhancing the quality of life for patients both locally and globally.

Locations

Toronto, Ontario, Canada

Patients applied

0 patients applied

Trial Officials

Allan Okrainec

Principal Investigator

University Health Network, Toronto

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported